Investment Memorandum · Preview
For informational purposes only. Not investment advice.
The Sherwin-Williams Company
SHW
May 27, 2026
The Sherwin-Williams Company (NYSE: SHW) is the world's largest paint and coatings company by revenue and market cap, founded in 1866, headquartered in Cleveland, OH. FY2025 revenue $23.57B (+2.0%); adj. EPS $11.43; ROIC ~20-25%. Three segments: Paint Stores Group (PSG, ~60% revenue) serving professional contractors through 4,800+ company-owned stores with same-day color-matched delivery; Consumer Brands Group (CBG, ~15%) including HGTV Home, Krylon, Minwax, Cabot, and Suvinil (Brazil's #1 paint, acquired Oct 2025); Performance Coatings Group (PCG, ~25%) serving auto refinish, industrial, protective, aerospace, and coil markets globally. CEO Heidi Petz (2024). SHW's moat is the irreplaceable PSG contractor store network with 50-80% IRR on new openings, built over 160 years.
▲ Bull Case
- ◆Housing recovery to 5.2M+ existing home sales by FY2027 drives PSG same-store sales +5-6%, gross margin leverage, and adj. EPS $16.50+ by FY2028 (27x = $446). At current 4.2M/yr sales, ~30% of normal repaint market is frozen by mortgage lock-in. Fed cuts to 5.5-6.0% will unlock pent-up demand.
- ◆Emerald Symmetry premium tier (April 2026: zero-VOC, plant-based, GREENGUARD Gold, LEED v5 certified) at 10-15% ASP premium targets high-spec projects. If Symmetry reaches $500M annual revenue at 55%+ gross margin, adds ~50bps company-wide margin and ~$0.70/share EPS.
- ◆Suvinil ($1.15B acquisition, Brazil's #1 paint at ~$525M revenue, 20%+ EBITDA margin) becomes platform for PSG-style contractor expansion across Latin America (Brazil, Peru, Chile, Colombia), creating growth outside US housing cycle.
▼ Bear Case
- ◆Tariff escalation on Chinese TiO2 combined with PSG SSS stagnation creates double compression: 100-150bps COGS increase plus flat volume = gross margin falls to 47-48% and adj. EPS stalls at $10-11. At 21x re-rating (from 27x) = $220 (-31% from $320).
- ◆Interest rate re-rating risk: At 27x P/E, SHW is priced for 'lower for longer' rates. If 10yr UST rises above 5.0-5.5%, stock re-rates to 22x P/E — a -19% pure multiple compression move independent of EPS. Underappreciated by buy-side.
- ◆CEO Petz unproven over full cycle (since Jan 2024). If Suvinil integration disappoints (CBG margins stay below 10%), or Petz pursues large M&A without ROIC justification, the quality thesis degrades.
“Is SHW's 27x FY2026E multiple justified by housing recovery optionality, or does it price perfection in a frozen market? Consensus (73% Buy, 24% Hold; median PT ~$400) is bullish but consistently surprised by stagnation duration. Bull camp: PSG network is irreplaceable; pent-up demand will surge when rates fall; EPS re-accelerates to $14-16. Bear camp: Mortgage lock-in (3% homeowners won't sell at 7%) is structural, not cyclical; SHW becomes a 2-3%/yr grower priced like 10%/yr compounder. Our view: Market prices housing recovery with 1-year delay (FY2027 vs FY2026). If recovery in FY2026, stock to $360-380. If stagnation through FY2027, stock stays $300-320. Tight range — stock appropriately priced at current earnings expectations.”
- ◆Fed rate cut 50bps+, 30yr mortgage below 6.5% (housing unlock, VERY HIGH)
- ◆Q2 2026 earnings: PSG same-store sales ≥3% (housing inflection confirmation, HIGH)
- ◆Existing home sales >4.5M monthly (mortgage lock-in break, HIGH)
- ◆Emerald Symmetry adoption disclosure Q3-Q4 2026 (premium product traction, MEDIUM)
- ◆Suvinil CBG margin ≥12% (integration success, MEDIUM)
- ◆Tariff escalation on TiO2 inputs (margin compression, BEAR, HIGH)
- ◆FY2026 guidance cut: PSG SSS <2% (recovery delayed, BEAR, HIGH)
- ◆10yr UST sustained >5.0% (multiple re-rating, BEAR, HIGH)
- ◆Housing stagnation continues through FY2027 (MEDIUM probability, HIGH severity): Mortgage lock-in structural; existing home sales stay 4.0-4.2M vs. historical 5M+
- ◆Tariff escalation on TiO2 raw materials from China (MEDIUM probability, HIGH severity): 150-200bps gross margin headwind with limited pricing power offset
- ◆10yr UST rises sustainably above 5.0-5.5% (LOW-MEDIUM probability, MEDIUM severity): 25% P/E compression (-$80) from cost-of-capital repricing independent of fundamentals
- ◆Suvinil integration disappoints, CBG margin stays <10% (LOW-MEDIUM probability, MEDIUM severity): $1.15B acquisition drag on amortization and friction for 7-10 years
- ◆CEO Petz executes large M&A ($5B+) without clear ROIC (LOW probability, MEDIUM severity): Valspar precedent ($11B, 2016) impaired multiples for 2+ years
Full Memo Continues
5 more sections, locked
- ●Valuation Range & DCFBase/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
- ●Risk/Reward AssessmentPosition-sizing framework with explicit upside/downside skew and entry conditions.
- ●Management & Capital AllocationMulti-year capital-allocation track record, incentive alignment, and management readout.
- ●Monitoring FrameworkWhat to watch each quarter — leading indicators and inflection signals tracked by the analyst.
- ●Unresolved QuestionsOpen analyst questions and follow-up research items — the depth signal.
For Agents — $2 per memo
Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.
GET /api/v1/research/SHW/memo Authorization: Bearer spt_...
Fund managers — coverage subscriptions launching soon. See marginofinsight.com.